Yoshitaka Maki

1.8k total citations
58 papers, 1.5k citations indexed

About

Yoshitaka Maki is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Yoshitaka Maki has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Organic Chemistry and 13 papers in Pharmacology. Recurrent topics in Yoshitaka Maki's work include Synthesis and biological activity (7 papers), Synthesis of Organic Compounds (7 papers) and Asthma and respiratory diseases (7 papers). Yoshitaka Maki is often cited by papers focused on Synthesis and biological activity (7 papers), Synthesis of Organic Compounds (7 papers) and Asthma and respiratory diseases (7 papers). Yoshitaka Maki collaborates with scholars based in Japan. Yoshitaka Maki's co-authors include Hisashi Kuriki, Taketoshi Saijo, Hideaki Nagaya, Haruhiko Makino, Yuzuru Ashida, Shinji Terao, Yasuko Ashida, Hiroshi Satoh, Shozo Yamamoto and Mitsuru Shiraishi and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Applied and Environmental Microbiology.

In The Last Decade

Yoshitaka Maki

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshitaka Maki Japan 19 542 317 257 236 216 58 1.5k
I. J. Zeitlin United Kingdom 20 344 0.6× 246 0.8× 190 0.7× 120 0.5× 75 0.3× 65 1.3k
Kyoichi Shimomura Japan 23 1.1k 2.1× 214 0.7× 310 1.2× 157 0.7× 355 1.6× 86 2.2k
Toshimitsu Yamada Japan 20 523 1.0× 139 0.4× 449 1.7× 110 0.5× 159 0.7× 52 1.6k
Danielle Denis Canada 24 597 1.1× 825 2.6× 451 1.8× 113 0.5× 478 2.2× 37 2.0k
Kartar Singh India 18 618 1.1× 178 0.6× 70 0.3× 216 0.9× 73 0.3× 58 1.3k
Andrea Steck Switzerland 23 689 1.3× 126 0.4× 241 0.9× 74 0.3× 212 1.0× 57 2.2k
Karsten Wassermann Denmark 28 1.5k 2.8× 116 0.4× 284 1.1× 312 1.3× 199 0.9× 64 2.4k
T. Berglindh Sweden 21 1.0k 1.9× 104 0.3× 189 0.7× 800 3.4× 60 0.3× 39 2.0k
S. L. Hempel United States 11 401 0.7× 265 0.8× 224 0.9× 86 0.4× 73 0.3× 17 1.2k
R. Jaques Switzerland 14 233 0.4× 257 0.8× 150 0.6× 75 0.3× 93 0.4× 85 1.1k

Countries citing papers authored by Yoshitaka Maki

Since Specialization
Citations

This map shows the geographic impact of Yoshitaka Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Maki more than expected).

Fields of papers citing papers by Yoshitaka Maki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Maki. The network helps show where Yoshitaka Maki may publish in the future.

Co-authorship network of co-authors of Yoshitaka Maki

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Maki. A scholar is included among the top collaborators of Yoshitaka Maki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Maki. Yoshitaka Maki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makino, Haruhiko, Takehiko Naka, Tetsushi Saino, & Yoshitaka Maki. (1988). Inhibitory effect of methyl 7-butyl-4,5,6,7-tetrahydro-3-methylamino-4,6-dioxo-5-propyl-2H-pyrazolo [3,4-d] pyrimidine-2-carboxylate (AA-2379) on type III allergic (Arthus) reaction. Inflammation Research. 25(3-4). 326–335. 3 indexed citations
2.
3.
Nagaya, Hideaki, Hiroshi Satoh, & Yoshitaka Maki. (1987). Possible mechanism of (H++K+)-ATPase inhibition by AG-1749, a proton pump inhibitor. The Japanese Journal of Pharmacology. 43. 6–6. 1 indexed citations
4.
Nagaya, Hideaki, Hiroshi Satoh, & Yoshitaka Maki. (1987). Actions of antisecretory agents on proton transport in hog gastric microsomes. Biochemical Pharmacology. 36(4). 513–519. 18 indexed citations
5.
6.
Ashida, Yasuko, et al.. (1986). Inhibition of the slow-reacting substance of anaphylaxis generation by ubiquinone derivatives.. Folia Pharmacologica Japonica. 88(3). 189–194. 1 indexed citations
7.
Saijo, Taketoshi, Haruhiko Makino, S Tamura, et al.. (1986). The Antiallergic Agent Amoxanox Suppresses SRS-A Generation by Inhibiting Lipoxygenase. International Archives of Allergy and Immunology. 79(3). 231–237. 12 indexed citations
8.
Satoh, Hiroshi, et al.. (1986). Antisecretory activity of AG-1749, a proton pump inhibitor. The Japanese Journal of Pharmacology. 40. 226–226. 7 indexed citations
9.
Satoh, Hiroshi, et al.. (1986). Spizofurone, a new anti-ulcer agent, increases alkaline secretion in isolated bullfrog duodenal mucosa. European Journal of Pharmacology. 124(1-2). 149–155. 1 indexed citations
10.
Inatomi, Nobuhiro, et al.. (1986). Indomethacin‐induced changes in canine gastric mucosal haemodynamics and haemoglobin oxygenation, and the effects of topical anti‐ulcer agents. Journal of Gastroenterology and Hepatology. 1(2). 87–96. 7 indexed citations
11.
Inatomi, Nobuhiro, Hiroshi Satoh, Hideaki Nagaya, & Yoshitaka Maki. (1985). Spizofurone (AG-629) increases gastric mucosal blood flow in dogs: A possible mechanism of its anti-ulcer effect. European Journal of Pharmacology. 110(3). 343–350. 4 indexed citations
12.
Saijo, Taketoshi, Hisashi Kuriki, Yuzuru Ashida, Haruhiko Makino, & Yoshitaka Maki. (1985). Inhibition by Amoxanox (AA-673) of the Immunologically, Leukotriene D<sub>4</sub>- or Platelet-Activating Factor-Stimulated Bronchoconstriction in Guinea Pigs and Rats. International Archives of Allergy and Immunology. 77(3). 315–321. 19 indexed citations
13.
Kawada, Mitsuru, Masazumi Watanabe, H. SUGIHARA, et al.. (1984). Spirocyclopropane compounds. III. Synthesis of spiro(benzofuran-2(3H),1'-cyclopropan)-3-ones for evaluation as gastric antisecretory and antiulcer agents.. Chemical and Pharmaceutical Bulletin. 32(9). 3532–3550. 7 indexed citations
14.
Satoh, Hiroshi, et al.. (1981). Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology. 81(4). 719–725. 95 indexed citations
15.
Satoh, Hiroshi, Naohisa Fukuda, Hisashi Kuriki, et al.. (1980). . Folia Pharmacologica Japonica. 76(7). 581–594. 3 indexed citations
16.
Kuriki, Hisashi, Taketoshi Saijo, Yoshitaka Maki, & Morio Kanno. (1979). Antiallergic action of 6-ethyl-3-(1h-tetrazol-5-yl) chromone (aa-344) on immediate hypersensitivity reaction in rats. The Japanese Journal of Pharmacology. 29(3). 385–397. 8 indexed citations
17.
Nohara, Akira, Hisashi Kuriki, Toshihiro Ishiguro, et al.. (1979). Studies on antianaphylactic agents. 6. Synthesis of some metabolites of 6-ethyl-3-(1H-tetrazol-5-yl)chromone and their analogs. Journal of Medicinal Chemistry. 22(3). 290–295. 17 indexed citations
18.
Maki, Yoshitaka, et al.. (1978). STIMULATORY EFFECTS OF SUBSTANCE P ON NEURITE EXTENSION AND CYCLIC AMP LEVELS IN CULTURED NEUROBLASTOMA CELLS. Journal of Neurochemistry. 30(6). 1321–1326. 97 indexed citations
19.
Satoh, Hiroshi, Yoshitaka Maki, & Morio Kanno. (1978). Biliary spasmolytic action of 3-(2,4,5-triethoxybenzoyl)propionic acid (AA-149) in dogs. European Journal of Pharmacology. 48(3). 309–317. 4 indexed citations
20.
Narumi, Shigehiko & Yoshitaka Maki. (1973). Possible role of cyclic AMP in gastric and secretion in rat. Activation of carbonic anhydrase. Biochimica et Biophysica Acta (BBA) - Biomembranes. 311(1). 90–97. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. J. Zeitlin Breakdown of academic impact, for papers by Kyoichi Shimomura Breakdown of academic impact, for papers by Toshimitsu Yamada Breakdown of academic impact, for papers by Danielle Denis Breakdown of academic impact, for papers by Kartar Singh Breakdown of academic impact, for papers by Andrea Steck Breakdown of academic impact, for papers by Karsten Wassermann Breakdown of academic impact, for papers by T. Berglindh Breakdown of academic impact, for papers by S. L. Hempel Breakdown of academic impact, for papers by R. Jaques
Rankless by CCL
2026